- Moody's•13 hours ago
New York, February 23, 2017-- Moody's Investors Service assigned a Baa3 rating to Abbott Laboratories' proposed new senior unsecured note offering. The rating outlook is stable. There are no changes to ...
- TheStreet.com•16 hours ago
Abbott Labs completed the acquisition of St. Jude Medical in January.
Analysts' forecast increases for EPS and sales
ABT : Summary for Abbott Laboratories Common Stoc - Yahoo Finance
Abbott Laboratories (ABT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||44.85 - 45.51|
|52 Week Range||36.76 - 45.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||48.45|
|Dividend & Yield||1.06 (2.36%)|
|1y Target Est||N/A|